Correction to: Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials

doi:10.1210/clinem/dgag275

Correction to: Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials

Journal: The Journal of clinical endocrinology and metabolism (Q1)
Published: 22 July 2026
Study design: Narrative review / expert opinion
Evidence level: Level 1, High (CEBM 1a)
PMID: 42485338
DOI: 10.1210/clinem/dgag275

Why clinicians should know about it

Picked for Endocrinology, Diabetes and Metabolism (top studies of the week, 26 July 2026).
Picked for Biochemistry (medical) (paper of the day, 23 July 2026).

View on PubMed Full text at the publisher Open in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.